Scientific Advisory Board

BCAN’s Scientific Advisory Board (SAB) is composed of distinguished leading academic urologists, oncologists, radiation oncologists, and pathologists working within the bladder cancer field, representing many of the major cancer centers in the U.S and Canada. All have made outstanding contributions in their own fields and we are proud to have their involvement on our behalf.
  • Donna Hansel, MD, PhD

    MD Anderson

    Oregon Health & Science, Portland OR Read More
  • Jean Hoffmann-Censits, MD

    John Hopkins Medical Institutions- Baltimore, MD

    John Hopkins Medical Institutions- Baltimore, MD Read More
  • Ashish M. Kamat, MD

    MD Anderson Cancer Center – Houston, TX

    MD Anderson Cancer Center – Houston, TX Read More
  • Lawrence Karsh, MD, FACS, CPI

    The Urology Center of Colorado – Denver, CO

    The Urology Center of Colorado – Denver, CO Read More
  • Louis L. Keeler III, MD

    New Jersey Urology- Voorhees, NJ

    New Jersey Urology- Voorhees, NJ Read More
  • William Kim, MD

    University of North Carolina, Chapel Hill

    William Y. Kim, MD, is the Rush S. Dickson Distinguished Professor of Medicine, Genetics, and Pharmacology at UNC-Chapel Hill. Kim is a laboratory-based physician-scientist. Clinically, Kim takes care of patients with genitourinary malignancies. The Kim Laboratory studies the genetics and cancer biology underlying the initiation and progression of bladder… Read More
  • Donald Lamm, MD, FACS

    BCG Oncology – Phoenix, AZ

    BCG Oncology – Phoenix, AZ Read More
  • Seth Lerner, MD

    Baylor College of Medicine – Houston, TX

    Baylor College of Medicine – Houston, TX Read More
  • Yair Lotan, MD

    UT Southwestern Medical Center – Dallas, TX

    UT Southwestern Medical Center – Dallas, TX Read More